Status:
RECRUITING
Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
Lead Sponsor:
Next Biomedical Co., Ltd.
Conditions:
Knee Osteoarthritis (Knee OA)
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Study in patients with knee osteoarthritis treated by embolization using NBGM200
Eligibility Criteria
Inclusion
- Osteoarthritis proven by MR-imaging
Exclusion
- Current local infection
- Life expectancy less than 6 months
Key Trial Info
Start Date :
April 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06930677
Start Date
April 17 2025
End Date
February 1 2027
Last Update
November 19 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium
2
Uz Leuven
Leuven, Belgium
3
Elisabeth-Tweesteden Hospital
Tilburg, Netherlands